2024-10-01 2025-09-30 2025-09-30 false 02748030 SUPREME HEALTH CARE LIMITED 2026-06-03 87300 false iso4217:GBP xbrli:pure 02748030 2024-09-30 02748030 2025-09-30 02748030 2024-10-01 2025-09-30 02748030 2023-09-30 02748030 2024-09-30 02748030 2023-10-01 2024-09-30 02748030 bus:SmallEntities 2024-10-01 2025-09-30 02748030 bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 02748030 bus:FullAccounts 2024-10-01 2025-09-30 02748030 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 02748030 core:WithinOneYear 2025-09-30 02748030 core:AfterOneYear 2025-09-30 02748030 core:WithinOneYear 2024-09-30 02748030 core:AfterOneYear 2024-09-30 02748030 core:ShareCapital 2025-09-30 02748030 core:SharePremium 2025-09-30 02748030 core:RevaluationReserve 2025-09-30 02748030 core:OtherReservesSubtotal 2025-09-30 02748030 core:RetainedEarningsAccumulatedLosses 2025-09-30 02748030 core:ShareCapital 2024-09-30 02748030 core:SharePremium 2024-09-30 02748030 core:RevaluationReserve 2024-09-30 02748030 core:OtherReservesSubtotal 2024-09-30 02748030 core:RetainedEarningsAccumulatedLosses 2024-09-30 02748030 core:LandBuildings 2025-09-30 02748030 core:PlantMachinery 2025-09-30 02748030 core:Vehicles 2025-09-30 02748030 core:FurnitureFittings 2025-09-30 02748030 core:OfficeEquipment 2025-09-30 02748030 core:NetGoodwill 2025-09-30 02748030 core:IntangibleAssetsOtherThanGoodwill 2025-09-30 02748030 core:ListedExchangeTraded 2025-09-30 02748030 core:UnlistedNon-exchangeTraded 2025-09-30 02748030 core:LandBuildings 2024-09-30 02748030 core:PlantMachinery 2024-09-30 02748030 core:Vehicles 2024-09-30 02748030 core:FurnitureFittings 2024-09-30 02748030 core:OfficeEquipment 2024-09-30 02748030 core:NetGoodwill 2024-09-30 02748030 core:IntangibleAssetsOtherThanGoodwill 2024-09-30 02748030 core:ListedExchangeTraded 2024-09-30 02748030 core:UnlistedNon-exchangeTraded 2024-09-30 02748030 core:LandBuildings 2024-10-01 2025-09-30 02748030 core:PlantMachinery 2024-10-01 2025-09-30 02748030 core:Vehicles 2024-10-01 2025-09-30 02748030 core:FurnitureFittings 2024-10-01 2025-09-30 02748030 core:OfficeEquipment 2024-10-01 2025-09-30 02748030 core:NetGoodwill 2024-10-01 2025-09-30 02748030 core:IntangibleAssetsOtherThanGoodwill 2024-10-01 2025-09-30 02748030 core:ListedExchangeTraded 2024-10-01 2025-09-30 02748030 core:UnlistedNon-exchangeTraded 2024-10-01 2025-09-30 02748030 core:MoreThanFiveYears 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments 2025-09-30 02748030 core:Non-currentFinancialInstruments 2024-09-30 02748030 dpl:CostSales 2024-10-01 2025-09-30 02748030 dpl:DistributionCosts 2024-10-01 2025-09-30 02748030 core:LandBuildings 2024-10-01 2025-09-30 02748030 core:PlantMachinery 2024-10-01 2025-09-30 02748030 core:Vehicles 2024-10-01 2025-09-30 02748030 core:FurnitureFittings 2024-10-01 2025-09-30 02748030 core:OfficeEquipment 2024-10-01 2025-09-30 02748030 dpl:AdministrativeExpenses 2024-10-01 2025-09-30 02748030 core:NetGoodwill 2024-10-01 2025-09-30 02748030 core:IntangibleAssetsOtherThanGoodwill 2024-10-01 2025-09-30 02748030 dpl:GroupUndertakings 2024-10-01 2025-09-30 02748030 dpl:ParticipatingInterests 2024-10-01 2025-09-30 02748030 dpl:GroupUndertakings core:ListedExchangeTraded 2024-10-01 2025-09-30 02748030 core:ListedExchangeTraded 2024-10-01 2025-09-30 02748030 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-10-01 2025-09-30 02748030 core:UnlistedNon-exchangeTraded 2024-10-01 2025-09-30 02748030 dpl:CostSales 2023-10-01 2024-09-30 02748030 dpl:DistributionCosts 2023-10-01 2024-09-30 02748030 core:LandBuildings 2023-10-01 2024-09-30 02748030 core:PlantMachinery 2023-10-01 2024-09-30 02748030 core:Vehicles 2023-10-01 2024-09-30 02748030 core:FurnitureFittings 2023-10-01 2024-09-30 02748030 core:OfficeEquipment 2023-10-01 2024-09-30 02748030 dpl:AdministrativeExpenses 2023-10-01 2024-09-30 02748030 core:NetGoodwill 2023-10-01 2024-09-30 02748030 core:IntangibleAssetsOtherThanGoodwill 2023-10-01 2024-09-30 02748030 dpl:GroupUndertakings 2023-10-01 2024-09-30 02748030 dpl:ParticipatingInterests 2023-10-01 2024-09-30 02748030 dpl:GroupUndertakings core:ListedExchangeTraded 2023-10-01 2024-09-30 02748030 core:ListedExchangeTraded 2023-10-01 2024-09-30 02748030 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-10-01 2024-09-30 02748030 core:UnlistedNon-exchangeTraded 2023-10-01 2024-09-30 02748030 core:NetGoodwill 2025-09-30 02748030 core:IntangibleAssetsOtherThanGoodwill 2025-09-30 02748030 core:LandBuildings 2025-09-30 02748030 core:PlantMachinery 2025-09-30 02748030 core:Vehicles 2025-09-30 02748030 core:FurnitureFittings 2025-09-30 02748030 core:OfficeEquipment 2025-09-30 02748030 core:AfterOneYear 2025-09-30 02748030 core:WithinOneYear 2025-09-30 02748030 core:ListedExchangeTraded 2025-09-30 02748030 core:UnlistedNon-exchangeTraded 2025-09-30 02748030 core:ShareCapital 2025-09-30 02748030 core:SharePremium 2025-09-30 02748030 core:RevaluationReserve 2025-09-30 02748030 core:OtherReservesSubtotal 2025-09-30 02748030 core:RetainedEarningsAccumulatedLosses 2025-09-30 02748030 core:NetGoodwill 2024-09-30 02748030 core:IntangibleAssetsOtherThanGoodwill 2024-09-30 02748030 core:LandBuildings 2024-09-30 02748030 core:PlantMachinery 2024-09-30 02748030 core:Vehicles 2024-09-30 02748030 core:FurnitureFittings 2024-09-30 02748030 core:OfficeEquipment 2024-09-30 02748030 core:AfterOneYear 2024-09-30 02748030 core:WithinOneYear 2024-09-30 02748030 core:ListedExchangeTraded 2024-09-30 02748030 core:UnlistedNon-exchangeTraded 2024-09-30 02748030 core:ShareCapital 2024-09-30 02748030 core:SharePremium 2024-09-30 02748030 core:RevaluationReserve 2024-09-30 02748030 core:OtherReservesSubtotal 2024-09-30 02748030 core:RetainedEarningsAccumulatedLosses 2024-09-30 02748030 core:NetGoodwill 2023-09-30 02748030 core:IntangibleAssetsOtherThanGoodwill 2023-09-30 02748030 core:LandBuildings 2023-09-30 02748030 core:PlantMachinery 2023-09-30 02748030 core:Vehicles 2023-09-30 02748030 core:FurnitureFittings 2023-09-30 02748030 core:OfficeEquipment 2023-09-30 02748030 core:AfterOneYear 2023-09-30 02748030 core:WithinOneYear 2023-09-30 02748030 core:ListedExchangeTraded 2023-09-30 02748030 core:UnlistedNon-exchangeTraded 2023-09-30 02748030 core:ShareCapital 2023-09-30 02748030 core:SharePremium 2023-09-30 02748030 core:RevaluationReserve 2023-09-30 02748030 core:OtherReservesSubtotal 2023-09-30 02748030 core:RetainedEarningsAccumulatedLosses 2023-09-30 02748030 core:AfterOneYear 2024-10-01 2025-09-30 02748030 core:WithinOneYear 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments core:CostValuation 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-10-01 2025-09-30 02748030 core:Non-currentFinancialInstruments core:CostValuation 2025-09-30 02748030 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-09-30 02748030 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-09-30 02748030 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-09-30 02748030 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-09-30 02748030 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-09-30 02748030 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-09-30 02748030 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-09-30 02748030 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-09-30 02748030 core:Non-currentFinancialInstruments core:CostValuation 2024-09-30 02748030 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-09-30 02748030 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-09-30 02748030 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-09-30 02748030 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-09-30 02748030 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-09-30 02748030 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-09-30 02748030 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-09-30 02748030 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-09-30 02748030 bus:Director1 2024-10-01 2025-09-30 02748030 bus:Director2 2024-10-01 2025-09-30 02748030 core:FurnitureFittingsToolsEquipment 2024-09-30 02748030 core:FurnitureFittingsToolsEquipment 2024-10-01 2025-09-30 02748030 core:FurnitureFittingsToolsEquipment 2025-09-30

SUPREME HEALTH CARE LIMITED

Registered Number
02748030
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2025

SUPREME HEALTH CARE LIMITED
Company Information
for the year from 1 October 2024 to 30 September 2025

Directors | Neel Chawla
| Saroj Rani Chawla

Registered Address | 16 Westfield Drive
| Gosforth
| Newcastle Upon Tyne
| NE3 4XU

Registered Number | 02748030 (England and Wales)

SUPREME HEALTH CARE LIMITED
Statement of Financial Position
30 September 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 572,941 |  |  |  | 576,399
|  |  |  | 572,941 |  |  |  | 576,399
Current assets |  |  |  |  |  |  |  |
Stocks | 4 | 453,159 |  |  |  | 453,159 |  |
Debtors |  | 142,800 |  |  |  | 200,985 |  |
Cash at bank and on hand |  | 46,255 |  |  |  | 71,592 |  |
|  | 642,214 |  |  |  | 725,736 |  |
Creditors amounts falling due within one year | 5 | (138,728) |  |  |  | (261,412) |  |
Net current assets (liabilities) |  |  |  | 503,486 |  |  |  | 464,324
Total assets less current liabilities |  |  |  | 1,076,427 |  |  |  | 1,040,723
Provisions for liabilities | 6 |  |  | (4,719) |  |  |  | (5,583)
Net assets |  |  |  | 1,071,708 |  |  |  | 1,035,140
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 2 |  |  |  | 2
Profit and loss account |  |  |  | 1,071,706 |  |  |  | 1,035,138
Shareholders' funds |  |  |  | 1,071,708 |  |  |  | 1,035,140

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 3 June 2026, and are signed on its behalf by:
Neel Chawla Director Registered Company No. 02748030

SUPREME HEALTH CARE LIMITED
Notes to the Financial Statements
for the year ended 30 September 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Basis of preparation
--- | ---
| The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

| Operating leases
--- | ---
| Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the Income Statement on a straight-line basis over the period of the lease. Where the company is a lessor, rental income from operating leases is credited to the Income Statement on a straight-line basis over the lease term.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to the Income Statement

| Current taxation
--- | ---
| Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

| Deferred tax
--- | ---
| Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows:

| Stocks and work in progress
--- | ---
| Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete). At each date of Statement of Financial Position, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete the sale. The impairment loss is recognised immediately in the Income Statement

| Trade and other debtors
--- | ---
| Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

| Financial instruments
--- | ---
| The company enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

| Government grants or assistance
--- | ---
| Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income. Grants of a revenue nature are recognised in the Income Statement in the same period as the related expenditure.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 19 |  | 19

3. | Tangible fixed assets
--- | ---

|  | Land & buildings |  | Fixtures & fittings |  | Office Equipment |  | Total
--- | --- | --- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
| Cost or valuation
| At 01 October 24 | 554,066 |  | 85,923 |  | 33,066 |  | 673,055
| Additions | - |  | - |  | 111 |  | 111
| At 30 September 25 | 554,066 |  | 85,923 |  | 33,177 |  | 673,166
| Depreciation and impairment
| At 01 October 24 | - |  | 67,886 |  | 28,770 |  | 96,656
| Charge for year | - |  | 2,705 |  | 864 |  | 3,569
| At 30 September 25 | - |  | 70,591 |  | 29,634 |  | 100,225
| Net book value
| At 30 September 25 | 554,066 |  | 15,332 |  | 3,543 |  | 572,941
| At 30 September 24 | 554,066 |  | 18,037 |  | 4,296 |  | 576,399

4. | Stocks
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Work in progress | 453,159 |  | 453,159
| Total | 453,159 |  | 453,159

5. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 6,645 |  | 10,544
| Taxation and social security | 32,459 |  | 28,578
| Other creditors | 99,624 |  | 222,290
| Total | 138,728 |  | 261,412

| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

6. | Provisions for liabilities
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Net deferred tax liability (asset) | 4,719 |  | 5,583
| Total | 4,719 |  | 5,583